An assessment of the efficacies and therapeutic interventions of homoeopathic medicines in combating viral disorders with implications in the treatment of SARS-CoV-2 (Covid-19), a global pandemic

Abstract

The prevalence of Severe Acute Respiratory Syndrome- Corona Virus-2 (SARS-CoV-2) has undergone a historic transition from December 2019 to April 2020. Under the current circumstances, SARS-CoV-2 has become a key problem for the public health and economic steadiness of the global fraternity. Based on ample of evidence from the global epidemiology of SARS-CoV-2 and MERS-CoV (Middle Eastern Respiratory Syndrome- Corona virus) scientists and physicians strappingly consider these viruses share structural and functional similarities of selected biologically active enzymes namely, 3CLpro, PLpro and RdRp. Ultra-diluted homoeopathic medicine has the legacy to combat infectious as well as viral diseases since last two centuries. Thus, existing antiviral homoeopathic therapies were meta-analysed in the current study and the need of appropriate clinical validation with proper in vitro as well as in vivo studies prior to make clinical endorsements in treating Covid-19 patients with homoeopathic medicines has been explained.